Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112726042 | 11272604 | 2 | F | 20150616 | 20160823 | 20150715 | 20160902 | EXP | US-ROCHE-1607777 | ROCHE | 72.00 | YR | F | Y | 74.00000 | KG | 20160902 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112726042 | 11272604 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | CYCEL=21?LAST DOSE PRIOR TO SAE ON 26/MAY/2015 (CYCLE 5, DAY1) | 125085 | 15 | MG/KG | INFUSION | |||||||
112726042 | 11272604 | 2 | SS | IPILIMUMAB | IPILIMUMAB | 1 | Intravenous (not otherwise specified) | LAST DOSE PRIOR TO SAE ON 05/MAY/2015 (CYCLE 4, DAY1) | 0 | 3 | MG/KG | ||||||||
112726042 | 11272604 | 3 | C | ASPIR 81 | 2 | 0 | |||||||||||||
112726042 | 11272604 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
112726042 | 11272604 | 5 | C | HEMP OIL | CANNABIS SATIVA SEED OIL | 1 | 0 | ||||||||||||
112726042 | 11272604 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
112726042 | 11272604 | 7 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
112726042 | 11272604 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
112726042 | 11272604 | 9 | C | MELATONIN | MELATONIN | 1 | 0 | ||||||||||||
112726042 | 11272604 | 10 | C | MILK THISTLE | MILK THISTLE | 1 | 0 | ||||||||||||
112726042 | 11272604 | 11 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
112726042 | 11272604 | 12 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
112726042 | 11272604 | 13 | C | NORVASC | AMLODIPINE BESYLATE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
112726042 | 11272604 | 1 | Malignant melanoma |
112726042 | 11272604 | 2 | Malignant melanoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
112726042 | 11272604 | OT |
112726042 | 11272604 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
112726042 | 11272604 | Hypertension | |
112726042 | 11272604 | Sudden death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
112726042 | 11272604 | 1 | 20150303 | 0 | ||
112726042 | 11272604 | 2 | 20150303 | 0 |